Case Report: Effective and Safe Treatment With Certolizumab Pegol in Pregnant Patients With Cogan’s Syndrome: A Report of Three Pregnancies in Two Patients

Case Report: Effective and Safe Treatment With Certolizumab Pegol in Pregnant Patients With Cogan’s Syndrome: A Report of Three Pregnancies in Two Patients

Cogan’s syndrome is a rare autoimmune disease characterized by ocular inflammation and audiovestibular manifestations. Treatment consists of systemic glucocorticoids and other immunosuppressive agents including methotrexate, cyclophosphamide and TNF-α-inhibitors. Due to potential ovarian or fetal to...

Full description

Bibliographic Details
Main Authors: Nils Venhoff, Jens Thiel, Markus A. Schramm, Ilona Jandova, Reinhard E. Voll, Cornelia Glaser
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Immunology
Subjects:
Cogan’s syndrome
pregnancy
vasculitis
TNF-α inhibitor
Certolizumab pegol
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.616992/full

Similar Items

Similar Items